A bispecific monoclonal antibody bsmab bsab is an artificial protein that can simultaneously bind to two different types of antigen bsmabs can be manufactured in several structural formats and current applications have been explored for cancer immunotherapy and drug delivery. Bispecific antibodies as the name suggests simultaneously target 2 or more tumor antigens on the same or separate cells to disrupt cancer development or progression others engage and tether
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )